✦ LIBER ✦

Ritanserin In Relapse Prevention In Abstinent Alcoholics: Results From a Placebo-Controlled Double-Blind International Multicenter Trial

✍ Scribed by G.A. Wiesbeck; H.-G. Weijers; J. Chick; C.A. Naranjo; J. Boening; Behalf of the Ritanserin in Alcoholism Work Group

Book ID: 109121327
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 709 KB
Volume: 23
Category: Article
ISSN: 0145-6008
DOI: 10.1111/j.1530-0277.1999.tb04105.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind, Placebo-Controlled Study

A Double-Blind, Placebo-Controlled Study of Naltrexone in the Treatment of Alcohol-Dependence Disorder: Results from a Multicenter Clinical Trial

✍ José Guardia; Carlos Caso; Francisco Arias; Antoni Gual; Jordi Sanahuja; Marisa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Glatiramer acetate in primary progressiv

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

✍ Jerry S. Wolinsky; Ponnada A. Narayana; Paul O'Connor; Patricia K. Coyle; Corey 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 2 views

## Abstract ## Objective To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis. ## Methods A total of 943 patients with primary progressive multiple sclerosis were randomized to GA or placebo (PBO) in this 3‐year, double‐blind tri

Rituximab in patients with primary progr

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro

Norfloxacin prevents spontaneous bacteri

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial

✍ Dr. Pere Ginés; Antoni Rimola; Ramón Planas; Victor Vargas; Francesc Marco; Manu 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 958 KB

Eighty cirrhotic patients who had recovered from an episode of spontaneous bacterial peritonitis were included in a multicenter, double-blind trial aimed at comparing long-term norfloxacin administration (400 mglday; 40 patients) vs. placebo (40 patients) in the prevention of spontaneous bacterial p

Amisulpride Does Not Prevent Relapse in

Amisulpride Does Not Prevent Relapse in Primary Alcohol Dependence: Results of a Pilot Randomized, Placebo-Controlled Trial

✍ Donata Marra; Dominique Warot; Ivan Berlin; Eric Hispard; Christine Notides; Sam 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views